Plasma homocysteine: an independent or an interactive risk factor for coronary artery disease
- 1 February 2005
- journal article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 352 (1-2) , 121-125
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Folic acid and vitamin B12 are more effective than vitamin B6 in lowering fasting plasma homocysteine concentration in patients with coronary artery diseaseEuropean Journal of Clinical Nutrition, 2004
- Homocysteine-induced thrombosisBritish Journal of Biomedical Science, 2004
- Homocysteine and cardiovascular disease: evidence on causality from a meta-analysisBMJ, 2002
- Homocysteine and Risk of Ischemic Heart Disease and StrokeJAMA, 2002
- Hyperhomocysteinemia, Vascular Function and Atherosclerosis: Effects of VitaminsCardiovascular Drugs and Therapy, 2002
- Randomized Trial of Folic Acid Supplementation and Serum Homocysteine LevelsArchives of internal medicine (1960), 2001
- Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)The Lancet, 2000
- Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European menThe Lancet, 2000
- Small LDL, Atherogenic Dyslipidemia, and the Metabolic SyndromeCirculation, 1997
- Hyperhomocyst(e)inemia. A common and easily reversible risk factor for occlusive atherosclerosis.Circulation, 1990